Noncurative Endoscopic Resection of Colorectal Adenocarcinoma (NoncurativeESD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03987828|
Recruitment Status : Not yet recruiting
First Posted : June 17, 2019
Last Update Posted : July 24, 2019
Patients with noncurative resection after ESD for CRC were considered for additional surgical treatment. Then, they either underwent surgery with curative intent or did not, according to patients choice and surgeons indication / contraindication.
We performed a retrospective revision of outcome data by clinical report review or phone calls.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Long-term Outcomes After Noncurative Endoscopic Resection of Colorectal Adenocarcinoma|
|Estimated Study Start Date :||July 31, 2019|
|Estimated Primary Completion Date :||September 30, 2019|
|Estimated Study Completion Date :||September 30, 2019|
- Survival [ Time Frame: 6 Months ]Overall survival cancer-specific survival and disease-free survival rate after noncurative ESD.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03987828
|Contact: Alessandro Repici, MDemail@example.com|